Promoting Your 510(k)-Pending Device: 5 Questions About FDA's Policy
Executive Summary
A 510(k) submission rather than a 510(k) clearance is the threshold that a device firm needs to meet to begin advertising or displaying a product under a long-established, one-sentence agency policy. But important questions remain about proper application of this policy by industry, Hyman, Phelps & McNamara attorney Jeffrey Shapiro writes in this guest column.
You may also be interested in...
Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention
Deal Watch: Novo Nordisk, Fauna To Explore Hibernation To Treat Obesity
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
Scrip’s Rough Guide On The State Of RNAi
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.
Need a specific report? 1000+ reports available
Buy Reports